Pathogen Co-aggregation and Exclusion at Urogenital Epithelial Surfaces

Pathogen Co-aggregation and Exclusion at Urogenital Epithelial Surfaces is a complex biological defense mechanism primarily mediated by commensal microbiota, such as Lactobacillus species, to maintain urogenital health. This process involves two distinct but synergistic actions: co-aggregation, where beneficial bacteria bind directly to pathogens to neutralize them or facilitate their clearance, and competitive exclusion, where commensals occupy epithelial binding sites to physically block pathogen colonization (Reid et al., 1998; Boris & Barbés, 2000). These interactions are facilitated by various molecular factors, including S-layer proteins, lipoteichoic acids, and biosurfactants produced by the commensal bacteria (Velraeds et al., 1998). While not a single molecular target like a receptor or enzyme, this mechanism is the functional objective of probiotic therapies aimed at preventing or treating conditions such as bacterial vaginosis and urinary tract infections (Reid & Burton, 2002). By restoring a dominant population of protective bacteria, these therapies leverage the exclusion and co-aggregation properties to displace pathogens and prevent biofilm formation (McMillan et al., 2011). Understanding the specific adhesins and environmental factors that influence these processes is essential for the development of next-generation live biotherapeutic products.

Other names

Microbial interferenceCompetitive exclusionBacterial co-aggregationProbiotic exclusion mechanismUrogenital microbial barrier

Competitive inhibition of pathogen adhesion to epithelial receptors and direct physical sequestration of pathogens through co-aggregation, often mediated by S-layer proteins and biosurfactants.